Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1990 1
1996 1
1997 1
2001 1
2003 1
2004 1
2006 4
2008 2
2009 4
2010 3
2011 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A Methyl Scan of the Pyrrolidinium Ring of Nicotine Reveals Significant Differences in Its Interactions with α7 and α4β2 Nicotinic Acetylcholine Receptors.
Xing H, Andrud KW, Soti F, Rouchaud A, Jahn SC, Lu Z, Cho YH, Habibi S, Corsino P, Slavov S, Rocca JR, Lindstrom JM, Lukas RJ, Kem WR. Xing H, et al. Among authors: soti f. Mol Pharmacol. 2020 Aug;98(2):168-180. doi: 10.1124/mol.119.118786. Epub 2020 May 30. Mol Pharmacol. 2020. PMID: 32474444 Free PMC article.
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia.
Tregellas JR, Tanabe J, Rojas DC, Shatti S, Olincy A, Johnson L, Martin LF, Soti F, Kem WR, Leonard S, Freedman R. Tregellas JR, et al. Among authors: soti f. Biol Psychiatry. 2011 Jan 1;69(1):7-11. doi: 10.1016/j.biopsych.2010.07.004. Epub 2010 Aug 21. Biol Psychiatry. 2011. PMID: 20728875 Free PMC article. Clinical Trial.
Initial phase 2 trial of a nicotinic agonist in schizophrenia.
Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR. Freedman R, et al. Among authors: soti f. Am J Psychiatry. 2008 Aug;165(8):1040-7. doi: 10.1176/appi.ajp.2008.07071135. Epub 2008 Apr 1. Am J Psychiatry. 2008. PMID: 18381905 Free PMC article. Clinical Trial.
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R. Olincy A, et al. Among authors: soti f. Arch Gen Psychiatry. 2006 Jun;63(6):630-8. doi: 10.1001/archpsyc.63.6.630. Arch Gen Psychiatry. 2006. PMID: 16754836 Clinical Trial.
Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia.
Tregellas JR, Olincy A, Johnson L, Tanabe J, Shatti S, Martin LF, Singel D, Du YP, Soti F, Kem WR, Freedman R. Tregellas JR, et al. Among authors: soti f. Neuropsychopharmacology. 2010 Mar;35(4):938-42. doi: 10.1038/npp.2009.196. Epub 2009 Dec 2. Neuropsychopharmacology. 2010. PMID: 19956085 Free PMC article. Clinical Trial.
21 results